Enovis director granted 9,346 common shares

Enovis CORP director Philip Okala received a grant of 9,346 shares of common stock.

Rhea-AI Filing Summary

Enovis CORP director Philip Okala received a grant of 9,346 shares of common stock. The award was recorded on May 19, 2026 at a stated price of $0.00 per share, indicating it was a compensation-related equity grant rather than an open-market purchase.

After this grant, Okala directly holds a total of 24,201 shares of Enovis common stock. The filing does not show any share sales, option exercises, or derivative positions; it only reports this single stock award and the resulting direct ownership level.

Insider Trade Summary

Grant/Award: 9,346 shares

Grant/Award 1 txn

Insider Okala Philip

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common stock, par value $0.001	9,346	$0.00	$0.00

Holdings After Transaction: Common stock, par value $0.001 — 24,201 shares (Direct)

Key Figures

Shares granted: 9,346 shares Grant price: $0.00 per share Shares held after: 24,201 shares +2 more

5 metrics

Shares granted 9,346 shares Common stock grant on May 19, 2026

Grant price $0.00 per share Stated price for awarded common stock

Shares held after 24,201 shares Direct common stock ownership after grant

Transaction code A Grant, award, or other acquisition of stock

Transaction direction acquire Equity award increasing direct holdings

Key Terms

Common stock, par value $0.001, Grant, award, or other acquisition, non-derivative, Form 4

4 terms

Common stock, par value $0.001 financial

"security_title: Common stock, par value $0.001"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

non-derivative financial

"transaction_type: non-derivative"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Enovis (ENOV) director Philip Okala report in this Form 4?

Director Philip Okala reported receiving 9,346 shares of Enovis common stock as a grant. The award was recorded at $0.00 per share, indicating a compensation-related equity grant rather than an open-market purchase, and increased his directly held stake to 24,201 shares.

Was the Enovis (ENOV) transaction by Philip Okala a stock purchase or a grant?

The transaction was a share grant, not a market purchase. The Form 4 shows 9,346 shares acquired with code “A” at $0.00 per share, which the filing describes as a grant, award, or other acquisition, consistent with equity compensation rather than a cash-funded buy.

How many Enovis (ENOV) shares does Philip Okala hold after this Form 4 transaction?

After the reported grant, Philip Okala directly holds 24,201 Enovis common shares. This total includes the 9,346-share award reported on May 19, 2026, and reflects his direct ownership position following the compensation-related acquisition disclosed in the filing.

Does the Enovis (ENOV) Form 4 for Philip Okala show any stock sales?

The Form 4 does not show any stock sales by Philip Okala. It reports only one transaction coded as an acquisition (grant/award) of 9,346 shares at $0.00 per share, with no dispositions, exercises, or derivative trades listed in the transaction or derivative summaries.

Are there any derivative securities reported for Philip Okala in this Enovis (ENOV) Form 4?

The filing does not list any derivative securities for Philip Okala. The derivative summary is empty, and the only reported transaction involves non-derivative common stock, indicating this Form 4 focuses solely on a direct stock grant and resulting share ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 08:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Okala Philip

(Last) (First) (Middle)

2711 CENTERVILLE ROAD

SUITE 400

(Street)

WILMINGTON DELAWARE 19808

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	05/19/2026		A		9,346	A	$0.0	24,201	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian P. Hanigan, attorney-in-fact	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)